Buy Sun Pharma for approx. 14% gain ( Target 600 )
已更新
1.Sun Pharma broke above its 200 DMA and tested it back again on weekly chart.
2. It has broken out of two consolidations:
a. Long term consolidation from 2019
b. short term consolidation from April 2020
TARGET : 600
C.P : 525
STOP LOSS: 515
2. It has broken out of two consolidations:
a. Long term consolidation from 2019
b. short term consolidation from April 2020
TARGET : 600
C.P : 525
STOP LOSS: 515
交易結束：達到停損點
STOPPED OUT
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。